Literature DB >> 28299922

Fabrication of Electrospun Mucoadhesive Membranes for Therapeutic Applications in Oral Medicine.

Martin E Santocildes-Romero1, Lucie Hadley1, Katharina H Clitherow1, Jens Hansen2, Craig Murdoch1, Helen E Colley1, Martin H Thornhill1,2, Paul V Hatton1.   

Abstract

Oral mucosal lesions are related to several etiologies, including trauma, infection, and immunologic and neoplastic diseases. Their prevalence varies greatly depending on ethnicity, gender, and exposure to risk factors. Currently, most oral mucosal lesions are treated with creams, mouthwashes, or gels containing suitable drugs. However, topical medications may be relatively ineffective as they are removed rapidly from oral surfaces, limiting drug contact times. Systemic medications might be more effective but are associated with unacceptable off-target side effects. The aim of this study was to produce novel polymeric mucoadhesive membranes for therapeutic applications on the oral mucosa using electrospinning. Poly(vinylpyrrolidone) (PVP) and Eudragit RS100 (RS100) were used for the fabrication of membranes, whereas dextran (Dex) or poly(ethylene oxide) (PEO) particles were incorporated to enhance their mucoadhesive properties. An electrospun poly(caprolactone) (PCL) backing layer (BL) was added to create a dual-layer system. Solution properties were studied using rheometry, and membranes were characterized using differential thermal analysis and scanning electron microscopy. Solubility, surface hydrophobicity, and adhesion properties were also investigated. The solution viscosity varied depending on the composition and concentration, affecting fiber production. The addition of RS100 to PVP resulted in reduced membrane porosity and solubility, and increased surface hydrophobicity and in vitro adhesion times. Dex and PEO particles were located on the surface of the fibers. A PCL BL was successfully produced, with enhanced attachment between layers achieved through thermal treatment. PVP homopolymer membranes did not adhere to plastic or porcine mucosa, whereas PVP/RS100 membranes with and without PEO or Dex were tightly adherent. In conclusion, PVP and RS100 may be combined to tailor membrane properties. Furthermore, electrospinning facilitated the production of membranes consisting of mucoadhesive-fabricated fibers displaying increased surface area and long-lasting adhesive properties. These novel compositions exhibit great potential for the fabrication of mucoadhesive patches for therapeutic applications in oral medicine.

Entities:  

Keywords:  electrospinning; membranes; mucoadhesive; oral medicine; oral patches

Mesh:

Substances:

Year:  2017        PMID: 28299922     DOI: 10.1021/acsami.7b02337

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  7 in total

1.  Large-Scale and Rapid Preparation of Nanofibrous Meshes and Their Application for Drug-Loaded Multilayer Mucoadhesive Patch Fabrication for Mouth Ulcer Treatment.

Authors:  Liang Wei; Shaohua Wu; Wen Shi; Amy L Aldrich; Tammy Kielian; Mark A Carlson; Runjun Sun; Xiaohong Qin; Bin Duan
Journal:  ACS Appl Mater Interfaces       Date:  2019-08-05       Impact factor: 9.229

Review 2.  Understanding and utilizing textile-based electrostatic flocking for biomedical applications.

Authors:  Alec McCarthy; Rajesh Shah; Johnson V John; Demi Brown; Jingwei Xie
Journal:  Appl Phys Rev       Date:  2021-12       Impact factor: 19.162

3.  Medium-Chain Fatty Acids Released from Polymeric Electrospun Patches Inhibit Candida albicans Growth and Reduce the Biofilm Viability.

Authors:  Katharina H Clitherow; Tahani M Binaljadm; Jens Hansen; Sebastian G Spain; Paul V Hatton; Craig Murdoch
Journal:  ACS Biomater Sci Eng       Date:  2020-05-20

4.  Mucoadhesive Electrospun Patch Delivery of Lidocaine to the Oral Mucosa and Investigation of Spatial Distribution in a Tissue Using MALDI-Mass Spectrometry Imaging.

Authors:  Katharina H Clitherow; Craig Murdoch; Sebastian Guy Spain; Anna Mette Handler; Helen E Colley; Mai Bay Stie; Hanne Mørck Nielsen; Christian Janfelt; Paul V Hatton; Jette Jacobsen
Journal:  Mol Pharm       Date:  2019-08-15       Impact factor: 4.939

5.  Corticosteroid delivery using oral mucosa equivalents for the treatment of inflammatory mucosal diseases.

Authors:  Zulfahmi Said; Craig Murdoch; Jens Hansen; Lars Siim Madsen; Helen E Colley
Journal:  Eur J Oral Sci       Date:  2021-03-01       Impact factor: 2.612

Review 6.  Engineering Electrospun Nanofibers for the Treatment of Oral Diseases.

Authors:  Yuanfei Wang; Yingnan Liu; Xiaopei Zhang; Na Liu; Xixi Yu; Meihua Gao; Wanchun Wang; Tong Wu
Journal:  Front Chem       Date:  2021-12-20       Impact factor: 5.221

7.  Three-dimensional bioprinting of mucoadhesive scaffolds for the treatment of oral mucosal lesions; an in vitro study.

Authors:  Maryam Koopaie; Duha Hayder Mohammad Ali Nassar; Mahvash Shokrolahi
Journal:  3D Print Med       Date:  2022-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.